Bookmark and Share

Detailed and Online Interactive Program




TUESDAY 20th MAY 2014
07:30 - 09:00 Registration 

 09:00 - 09:25

Welcome by MIXiii Chairpersons

Yoav Chelouche - Partner, Aviv Venture Capital, Co-Chairman, IATI

Ruti Alon - General Partner, Pitango Venture Capital

Dr. Benny Zeevi - Managing General Partner, DFJ Tel Aviv Venture Partners, Co-Chairman, IATI 

Prof. Yesha Sivan - Executive Director, Coller Institute of Venture at Tel Aviv University 

Avi Hasson - Chief Scientist of the Ministry of Economy, Israel


H.E. Mme. Liu Yandong, Vice Premier, State Council, P.R.China

Fireside Chat with The Honorable President of the State of Israel, Mr. Shimon Peres

Interviewer: Mr. David Rowan - Editor of WIRED magazine, UK Edition 
10:15 - 11:15

Hall A

CEO Panel

Moderator: Yossi Vardi

Michel Combes - Chief Executive Officer, Alcatel Lucent

Weili Dai - President and Co-Founder, Marvell Technology Group

Barry Greene - President & Chief Operating Officer, Alnylam Pharmaceuticals

Charles N. Kahn III - President and Chief Executive Officer, Federation of American Hospitals

11:15 - 11:45 Coffee Break
11:45 - 12:30

Hall A

Keynote Lecture

Winning in the Age of Revolution
Erez Vigodman, President and Chief Executive Officer, Teva

12:30 - 13:15

Hall A

Keynote Lecture

Health Reform 101 - Its Impact on the USA Healthcare Ecosystem
Charles M. Kahn, President and Chief Executive Officer, Federation of American Hospitals

13:15 - 14:00 Lunch Break
14:00 - 14:45

Hall A

Keynote Lecture

Current State of the Life Science Capital and Strategic Markets
Jeffrey Hoffman, Managing Director J.P Morgan

14:45 - 15:45 

Hall A

The Med Tech Makeover:  Beauty Tips from the Big Boys

Moderator: Jonathan Silverstein, General Partner and Co-Head of Venture Capital, OrbiMed
Chris King, Vice President, Business Development and Strategic Partnering Cardiac Rhythm Disease Management, Medtronic, Inc.
David Neustaedter, Vice President, Covidien Ventures
Rafael Torres, Sr. Managing Director & Head of Healthcare, GE Ventures
Brad Vale, PhD, DVM, Head of Johnson & Johnson Development Corporation (JJDC)
Albert A. Lauritano, MS, CLP, Director, Technology Licensing & Collaboration, BD Technologies

15:45 - 16:10 Coffee Break

16:10 - 18:30

Hall H

Company Presentations


Hall I

Company Presentations


Hall K

Company Presentations


Hall L

Company Presentations


Hall M

Company Presentations


Hall A

From Translational Research to Deal Making



Innovative Funding of Translational Research

Moderator: Amir Naiberg - CEO Yeda R&D Co. Ltd - Technology Transfer from the Weizmann Institute of Science

Integra Fund: Yaacov Michlin - President & CEO Yissum

T3 Fund: Benjamin Soffer - Manager, Technion R&D Foundation, Technology Transfer Office 

Momentum Fund: Shlomo Nimrodi - CEO, Ramot at Tel Aviv University 

Hadasit Fund: Dr. Tamar Raz

Sourasky Hospital: Dr. Michal Roll



Deal Making with Academy 

Moderator: Yael Baratz -Senior Partner, Pearl Cohen Zedek Latzer Baratz  

Dr. Mira Peled - CEO of AIT

Prof. Oded Shoseyov - Founder and CSO, Collplant

Louis P. Berneman - Founding Partner, Osage University Partners

Chaim Lebovits - CEO, Brainstorm

David Malek - VP of Business Development, BiolineRX

Zeev Zehavi - VP, Venture Investments Europe and Israel, J&J

16:10 - 16:30 Oramed Pharmaceuticals: Overcoming the Challenges of Oral Protein Delivery Maxillent Ltd.: A Minimally Invasive Solution for the Sinus Lift Procedure   Brainsway Deep TMS - Breakthrough in Brain Treatment KAHR Medical LTD: Bifunctional Hexamers of the TNF ligand Superfamily  Treato Ltd: The Future of Patient Insights: How Big Data is Forging New Paths to the Empowered Patient




16:30 - 16:50 Atox Bio: Developing AB103 for Flesh Eating Bacteria Nephera Ltd.: Protecting the Kidneys in Acute Heart Failure ProstaGene: Prostate Cancer- New Diagnostic and Prognostic Tests and New Treatment for Metastatic Disease BiondVax Pharmaceuticals Ltd: Pandemic Preparedness Ahead of Outbreak - BiondVax's Universal Flu Vaccine Corbus Pharma: Resunab, a novel Phase II Drug for Life Threatening Rare Inflammatory Diseases
16:50 - 17:10 ViDAC Pharmaceuticals: Breakthrough Cancer Drugs that Target Cancer Metabolism  Leviticus Cardio: Wireless Solution for LVAD System  Sight Diagnostics: A Computer Vision Platform for Disease Diagnosis MedAware Ltd: Eliminating Prescription Errors: A Systematic Approach Enzymotec: Mimics the Human Milk Fat - the Way Nature Intended
17:10 - 17:30 TheraCoat: New Hydrogel-Based Drug Delivery System Promises to Optimize Treatment for Bladder Diseases  Cardiogard Medical Ltd.: Cerebral Protection During Open Heart Surgery HeadSense Medical: Non-invasive Intracranial Pressure Monitor LifeBEAM Technologies Ltd.:  Advanced Bio-sensing Technology, from Aerospace to Consumer Wearables OpisoftCare: From Unstructured Clinical Data to Meaningful and Accessible Insight
17:30 - 17:50 Improdia Ltd.: Innovative Test Kit for Monitoring the Immune System Status Wellsense Technologies Ltd.: Continuous Bedside Pressure Mapping - Improving Patient Care and Financial Outcomes MobileOCT: Expanding Cervical Cancer Diagnostics to Emerging Economies Oggii: Pet Healthcare  Apos Medical & Sports Technologies:  AposTherapy, A Breakthrough Personalized and Non-Invasive Treatment for Knee & Back Pain
17:50 - 18:10 Tiltan Pharma Ltd.: Developing TL-118 an Oral Anti-angiogenic Treatment for Cancer Teva Pharmaceuticals Ltd: Teva Israel: Collaborate for Better Health  Medasense Biometrics Ltd.: Medasense Pain Monitoring Systems - Objective Assessment. Better Results. Night-Sense: Sweet Dreams for People with Diabetes Nano Retina
18:10 - 18:30 Peritech Pharma: Novel Drug Delivery Platform InsuLine Medical: InsuPad - Safe for Targeted Therapy IMEXCO General Ltd.: Neuro-CPD, a Chronic Pain Detector  EarlySense: Contact-free Patient Monitoring Solutions
Neuron Guard S.r.l.s
18:30 - 20:30 MIXiii 2014 Gala Event Biomed & Hi-Tech    Hall 1


08:00 - 09:00 Registration 
09:00 - 09:45

Hall A

Keynote Lecture

The Age of 3D Printing
Avi Reichental, CEO, 3D System

09:45  -10:30


Hall A

Keynote Lecture 

The Role of Integrated Technologies in the Innovation of Medical Practice
Dr. C. Martin Harris, CIO / Chairman, Cleveland Clinic

10:30 - 11:00 Coffee Break
11:00 - 11:45

Hall A

Keynote Lecture

The Purpose of The Medical Device Industry: Solving for Variability

Dan Wildman, WW President, Ethicon Biosurgery

11:45 - 12:30

Hall A

Keynote Lecture

The Importance of Innovation in a Time of Healthcare Transformation

Gary L. Gottlieb, M.D, M.B.A President and Chief Executive Officer Partners Healthcare System, Inc. 

12:30 - 13:30 Lunch Break
13:30 - 14:30

Hall A

The Changing Landscape of Pricing and Reimbursement

Moderator: Barry Greene, President & Chief Operating Officer, Alnylam Pharmaceuticals
Dr. Kevin Schulman, Professor of Medicine, Duke University School of Medicine
Thomas McCourt, Chief Commercial Officer, Ironwood Pharmaceuticals, Inc.

14:30 - 15:00 Coffee Break
 14:00 - 18:00

Hall E
Connected Health

14:00-15.30  Connected Health Stakeholders' View.

15:30-16:00   Coffee Break

16:00-17:00  Panel Discussion Opportunities and Challenges of Connected Health

Moderator: Yael Glassman - VP Marketing  & Business Development, Sensible Medical

Wendy Mayer - Vice President, Worldwide Innovation, Pfizer

Jack Young - Director, Qualcomm Life Fund, Qualcomm Ventures

Bethany Hills - Partner , Epstein Becker & Green

Thierry Zylberberg - Executive Vice President, Head of Orange Healthcare

Peggy Wang - LongTec China Venture


17:00-18:00  Company Presentations







15:00 - 18:20

Hall H

Company Presentations

Hall I

Company Presentations 

Hall K

Company Presentations

Hall L

Company Presentations


Hall M

Company Presentations


Hall A

15:00 - 16:40

Panel Riding the IPO Wave

Moderator: Chaim Friedland - Partner, Gornitzky & Co.

Gil Bar Nahum - Managing Director, Jeffries & Co.

Netanel (Natti) Ginor - Managing Director, Jeffries & Co.

Dvid Tsur - Chief Executive Officer, Kamada Ltd.

Dr. Yaron Daniely - Chief Executive Officer, Alcobra Ltd.

 Hani Shitrit Bach - Senior Vice President, Tel Aviv Stock Exchange


Hall A

16:40 - 17:40

Panel  Effective and Efficient Clinical R&D - Taking Advantage of the UK's Expert Research Infrastructure

Overview of UK NIHR and R&D Processes of Industry Engagement

Dr Matthew Hallsworth - Head of External Relations, NOCRI & Ravi Chana - Business Development Manager, NOCRI

Company Presentations and Panel (Experiences of Israeli Companies working with NIHR)

Moderator: Dr. Matthew Hallsworth -  Head of External Relations, NOCRI

Teva - Tami Yardeni, Vice President Global Clinical Operations

Media Cancer Screening - Rami Sharon,  Executive Vice President

NIHR Clinical Research Network - Divya Chada Manek, Industry Business Development 

EarlySense - Guy Auberbach, Sales Director


15:00 - 15:20 Intec Pharma: Meeting The Unmet Need in Drug Delivery  Spring Biomed: Spectral Virtual Biopsy Revolutionary Medical Diagnostics Based on Military Technology for Spectral Imaging  Fertiprot: Crossing the Barrier for More Efficient Reproduction and Increased Take-Home Baby Rate BioZEEN ( Bangalore Biotech Labs Pvt. Ltd.): Efficient bio-pharmaceutical Fermentation Through Customized, Process Optimized Smart Equipments and Unique gmp Certified Bio-pilot Laboratory Training on Best Practices, A Synergistic Dual Recipe for Enhanced Yields Genome Compiler: CAD for Life
15:20 - 15:40 Compugen: Predictive Discovery of Novel Targeted Medicines Glusense: Implantable Glucose Monitor Real Imaging: A Novel Technology for Breast Cancer Detection and Risk Assessment NAMSA: Preclinical, Clinical, Regulatory: NAMSA Gets You to Market Faster MediWound: Discover Enzymatic Surgery
15:40 - 16:00 Pepticom LTD: Revolutionizing Peptide Drug Discovery  BioControl Medical: Neurostimulation for the Treatment of Heart Failure NovellusDx: A New Era in Personalized Medicine AiM GmbH, Assesment-in-Medicine: Reimbursement Hurdles in the EU and Germany cCAM Biotherapeutics: First in Class Immunomodulatory mAb to Treat Cancer 
16:00 - 16:20 PolyPid Ltd.: PolyPid - Novel Prolonged And Controlled Drug Delivery Platform CartiHeal Ltd.: Novel Implant for Cartilage Regeneration Kadimastem Ltd.: Cellular Theraputics to Treat Diabetes and ALS Avalere Health: Reimbursement Experts: Avalere Health Applied Immune Technologies (AIT) Ltd: Novel Therapeutic Recombinant Antibodies Targeting the Intracellular Proteom
16:20 - 16:40 VaxilBio: Superior Antigens for Improved Therapeutic Vaccines and Antibodies Pluristem: Cell Therapy - From the Bench to Multi-National Clinical Studies  BiolineRX Sealantis: Alga Mimetic Tissue Adhesives Silenseed: RNAi-based Medicine - Clinical Evidences from Treatment of Pancreatic Cancer
16:40 - 17:00 CollPlant Ltd.: Plant Derived rhCollagen Products for Tissue Repair  RealView Imaging Ltd.:   Live Interactive 3D Holographic Imaging, First in Human Experiences BioCEP Ltd: The CEPir Device for High Quality Magnetic Cell Separation Cote Orphan Consulting: FDA Orphan Drug Designation Mini-workshop -Tips from the Master Teva Pharmaceuticals Ltd.: The Promise of Personalized Medicine - Treating the Patient with the Right Drug at the Right Time
17:00 - 17:20 Alcobra: A Clinical-Stage CNS-focused Specialty Biopharmaceutical Company

KAMADA: Plasma-Derived Protein Therapeutics for Orphan Indications

Protalix Biotherapeutics: Advances in Clinical Development of the Oral Treatment for Gaucher and Enzyme Replacement Therapy for Fabry  Global Cardiovascular Innovation Center: The New World in Healthcare Delivery and its Effects on Innovation - A view from the Cleveland Clinic Access for Life: Safer, Cheaper Vascular Access
17:20 - 17:40 Azure PCR:  qPCR Analysis: Accurate and Automatic PRO-IV Medical: A Mobile Platform for Managing and Monitoring of Errors During Infusion Therapy Cell Cure Neurosciences Ltd.: Fighting Blindness with a Stem Cell Therapy Finnegan: New Patenting Techniques For Attracting Medical Device Investors IonMed: Cold-Plasma-Based Surgical and Healing Technology
17:40 - 18:00 Quiet Therapeutics: Gagomers - Novel Targeted Nanoclusters for Therapeutic Intervention in Cancer Artack Medical: A Quantum Leap in Hernia Mesh Fixation Prestwick Chemical SAS: Smart Compound Libraries and Smart Hit-Follow-up, a Powerful Approach to Generate Novelty in Drug Discovery Programs Marx Biotechnology: Diagnostic Kit for Early Detection of GVHD - Saving Thousands of Lives Anually Finnegan: Insider Patenting Tips for Boosting High Tech Valuation 
18:00 - 18:20 Foamix: Foamix Transforms into a Specialty Pharmaceutical Company Based On Successful Phase 2 Clinical Trials  LifeBond Ltd: Surgical Biomaterials for Improved Patient Care BioCancell: Bladder Cancer Opportunity NanoVibronix Ltd.: PainShield Ultrasound Therapy - A Paradigm Shift in Pain Management Moebius Medical Ltd.: A New Concept in Intra-Articular Therapy for Osteoarthritis


THURSDAY 22nd MAY 2014
08:00 - 09:00 Registration 
09:00 - 10:30

 Hall A

Building Innovation Ecosystems

Chairperson: Avi Hasson, Chief Scientist of the Ministry of Economy, Israel

Opening Remarks: Mr. Naftali Bennett, Minister of Economy, Israel 

Overview: Mr Avi Hasson, Chief Scientist of the Ministry of Economy, Israel 


General Session:

HeuiJae Pahk, President and National CTO, Office of Strategic R&D Planning, Ministry of Trade, Industry and Energy Republic of Korea

S. R. Patil, Honorable Minister for Planning, Statistics, Information Technology, Biotechnology and Science and Technology, Government of Karnataka

Dr. Mark Shmulevich - Deputy Minister of Communications, Russia

Maxine Fassberg - Vice President, Technology and Manufacturing Group, General Manager of Intel Israel

10:30 - 11:00 Coffee Break
11:00 - 11:45

Hall A

Keynote Lecture

Getting Paid for your Products in the US and Europe - Medical Device, Pharma and HealthIT

Susan W. Berson, Managing Member, Mintz Levin

11:45 - 12:30

Hall A

Keynote Lecture

Frontiers in the Development, Manufacture and Use of New Therapies

Kieran Murphy, President and CEO, GE Health Care, Life Sciences Division

12:30 - 13:30 Lunch Break
13:30 - 14:15

Hall A

Keynote Lecture

New Era in Pharma: Pertinent Issues and Their Implications for Pharmaceutical Companies and Business Development

Sophie Kornowski - Bonnet, Head of Roche Partnering Roche 


 Hall H

Company Presentations

Hall I

Company Presentations

Hall K

Company Presentations

Hall L

Company Presentations

Hall M

Company Presentation

Tonix Pharmaceuticals Corp.(TNXP): Is Sleep Disturbance an Achilles Heel of the Fibromyalgia and PTSD Monsters? StarletDerma: A Natural, Marine Extracted Micro-Injuction Delivery Platform  Solubest: Capitalizing on Proprietary Platforms for Drug Re-profiling   Quasar: CGMP Compatible Production in China - From Dream to Reality Trendlines: Pitfalls of Medical Technology Investments
Immune Phamaceuticals: Personalized Medicine and Targeted Therapies for Better Outcomes Aposense: From Depot To Target, Enhancing Effectiveness And Safety Of Known Drugs CoreBone: Bioactive Coral Bone Graft
EcoFusion: Rapid Self Change Using Wearables
14:55-15:30 Coffee Break
15:30-17:00 WOW Biomed Competition


MIXiii Start-up Awards and Reflection

Biomed: Dr. Irit Yaniv & Dr. Benny Zeevi, Managing General Partner, DFJ Tel Aviv Venture Partners, Co-Chairman, IATI 

Hi-Tech: David Stark, OurCrowd & Prof. Yesha Sivan, Executive Director, Coller Institute of Venture at Tel Aviv University


Organized By:
kenes iati
Kenes Exhibitions Organizers of Exhibitions Ltd. 
Kenes Building, Airport city 70151 P.O.Box 56, Ben-Gurion Airport 70100, Israel